Gleevec inventor from Novartis visits Korea.

Published: 2005-06-16 06:58:00

Updated: 2005-06-16 06:58:00

Dr. Alex Matter, the developer of Gleevec and the chief researcher of Novartis tropical medicine institute will visit to "Bio camp" of Korea and deliver a lecture titled "new drug development in the third millennium era" for research workers in the pharmaceutical industry and college students of...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK